These findings were consistent with the study of Lomnytska et al., in that they reported those patients with the high PRDX2 expression has a shorter survival time than those who with a low PRDX2 expression in squamous cervical cancer [34]. Here, PRDX2 is linked to cervical squamous cell carcinoma.